- Home
- ISPR vs MBOT Comparison
ISPR vs MBOT Comparison
Compare ISPR & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ISPR | MBOT |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.5M | 75.2M |
| IPO Year | 2023 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ISPR | MBOT |
|---|---|---|
| Price | $1.48 | $0.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.90 | ★ $6.33 |
| AVG Volume (30 Days) | 15.8K | ★ 690.7K |
| Earning Date | 11-05-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 15.94 | ★ 60.27 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $96,014,610.00 | $116,887.00 |
| Revenue This Year | $16.14 | N/A |
| Revenue Next Year | $8.92 | $475.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | $0.93 |
| 52 Week High | $3.87 | $2.86 |
Technical Indicators
Market Signals| Indicator | ISPR | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 51.72 | 19.55 |
| Support Level | $1.41 | N/A |
| Resistance Level | $1.65 | $2.21 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 43.25 | 9.44 |
Price Performance
Historical ComparisonAbout ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.